Carmen Martínez‐Cué

Universidad de Cantabria — Spain

Medicine · Health Sciences

31h-index3.1kcitations67works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Down syndrome and intellectual disability research(46), Genetics and Neurodevelopmental Disorders(16), Alzheimer's disease research and treatments(13), Autism Spectrum Disorder Research(8), Neuroinflammation and Neurodegeneration Mechanisms(8)

Publications67 total

Oxidative-Stress-Associated Proteostasis Disturbances and Increased DNA Damage in the Hippocampal Granule Cells of the Ts65Dn Model of Down Syndrome
Antioxidants·2022· 12 citedOpen Access
Fatty Acids: A Safe Tool for Improving Neurodevelopmental Alterations in Down Syndrome?
Nutrients·2022· 9 citedOpen Access
Bexarotene Impairs Cognition and Produces Hypothyroidism in a Mouse Model of Down Syndrome and Alzheimer’s Disease
Frontiers in Pharmacology·2021· 15 citedOpen Access
Nuclear Reorganization in Hippocampal Granule Cell Neurons from a Mouse Model of Down Syndrome: Changes in Chromatin Configuration, Nucleoli and Cajal Bodies
International Journal of Molecular Sciences·2021· 15 citedOpen Access
Down syndrome is an oxidative phosphorylation disorder
Redox Biology·2021· 31 citedOpen Access
Early postnatal oleic acid administration enhances synaptic development and cognitive abilities in the Ts65Dn mouse model of Down syndrome
Nutritional Neuroscience·2020· 5 citedOpen Access
Signalling Pathways Implicated in Alzheimer′s Disease Neurodegeneration in Individuals with and without Down Syndrome
International Journal of Molecular Sciences·2020· 26 citedOpen Access
Antioxidants in Down Syndrome: From Preclinical Studies to Clinical Trials
Antioxidants·2020· 32 citedOpen Access
Prenatal, but not Postnatal, Curcumin Administration Rescues Neuromorphological and Cognitive Alterations in Ts65Dn Down Syndrome Mice
Journal of Nutrition·2020· 14 citedOpen Access
Prenatal Administration of Oleic Acid or Linolenic Acid Reduces Neuromorphological and Cognitive Alterations in Ts65dn Down Syndrome Mice
Journal of Nutrition·2020· 24 citedOpen Access
Cellular Senescence in Neurodegenerative Diseases
Frontiers in Cellular Neuroscience·2020· 255 citedOpen Access
Translational validity and implications of pharmacotherapies in preclinical models of Down syndrome
Progress in brain research·2019· 26 cited
Translating molecular advances in Down syndrome and Fragile X syndrome into therapies
European Neuropsychopharmacology·2018· 14 cited
Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome
Brain Research Bulletin·2018· 18 cited
Anti-IL17 treatment ameliorates Down syndrome phenotypes in mice
Brain Behavior and Immunity·2018· 29 citedOpen Access
Common Pathogenic Mechanisms between Down Syndrome and Alzheimer's Disease: Steps toward Therapy
2018
The GABA A α5-selective Modulator, RO4938581, Rescues Protein Anomalies in the Ts65Dn Mouse Model of Down Syndrome
Neuroscience·2017· 10 cited
Cerebellar alterations in a model of Down syndrome: The role of the Dyrk1A gene
Neurobiology of Disease·2017· 20 citedOpen Access
Pre- and post-natal melatonin administration partially regulates brain oxidative stress but does not improve cognitive or histological alterations in the Ts65Dn mouse model of Down syndrome
Behavioural Brain Research·2017· 16 cited
Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders
Current Medicinal Chemistry·2017· 74 cited
page 1 of 4Next →

Frequent Co-authors

Noemı́ Rueda(29), Jesús Flórez(16), Verónica Vidal(16), Susana García-Cerro(15), Mara Dierssen(12), Andrea Corrales(9), J. Flórez(8), Sara Lantigua(8), Carmela Baamonde(7), Paula Martínez(7), Emilio J. Sánchez‐Barceló(5), Iria F. Vallina(4), Rebeca Vidal(4), José Luís Trejo(4), María Llorens‐Martín(4), Renata Bartesaghi(4), Eva María Pérez García(3), Marie‐Claude Potier(3), M Lumbreras(3), Alba Puente(3)